BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1837798)

  • 1. Positron emission tomography applied in the study of pituitary adenomas.
    Muhr C; Bergström M
    J Endocrinol Invest; 1991 Jun; 14(6):509-28. PubMed ID: 1837798
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study.
    Bergström M; Muhr C; Lundberg PO; Bergström K; Gee AD; Fasth KJ; Långström B
    J Comput Assist Tomogr; 1987; 11(5):815-9. PubMed ID: 3498743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT.
    Pirker W; Riedl M; Luger A; Czech T; Rössler K; Asenbaum S; Angelberger P; Kornhuber J; Deecke L; Podreka I; Brücke T
    J Nucl Med; 1996 Dec; 37(12):1931-7. PubMed ID: 8970508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical application of 11C-NMSP to the patients with pituitary adenoma other than prolactinoma].
    Momose T; Teramoto A; Nishikawa J; Inoue Y; Watanabe T; Sasaki Y
    Kaku Igaku; 1993 Jun; 30(6):627-35. PubMed ID: 8345693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant prolactinoma with multiple intracranial metastases studied with positron emission tomography.
    Muhr C; Bergström M; Lundberg PO; Hartman M; Bergström K; Pellettieri L; Långström B
    Neurosurgery; 1988 Feb; 22(2):374-9. PubMed ID: 3258413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to bromocriptine in prolactinomas.
    Pellegrini I; Rasolonjanahary R; Gunz G; Bertrand P; Delivet S; Jedynak CP; Kordon C; Peillon F; Jaquet P; Enjalbert A
    J Clin Endocrinol Metab; 1989 Sep; 69(3):500-9. PubMed ID: 2760167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromocriptine reduction of prolactinoma size.
    Corenblum B; Hanley DA
    Fertil Steril; 1981 Dec; 36(6):716-9. PubMed ID: 7308514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bromocriptine for prolactin-secreting adenomas: analysis by CT scan.
    Niwa J; Sato O; Tanabe S
    Comput Radiol; 1983; 7(4):237-41. PubMed ID: 6641185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET as a tool in the clinical evaluation of pituitary adenomas.
    Bergström M; Muhr C; Lundberg PO; Långström B
    J Nucl Med; 1991 Apr; 32(4):610-5. PubMed ID: 2013801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo measurement of dopamine receptors in pituitary adenomas using positron emission tomography.
    Muhr C; Bergström M; Lundberg PO; Bergström K; Långström B
    Acta Radiol Suppl; 1986; 369():406-8. PubMed ID: 2980511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid metabolism in pituitary adenomas.
    Bergström M; Muhr C; Lundberg PO; Bergström K; Lundqvist H; Långström B
    Acta Radiol Suppl; 1986; 369():412-4. PubMed ID: 2980512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET studies with L-[1-11C]tyrosine, L-[methyl-11C]methionine and 18F-fluorodeoxyglucose in prolactinomas in relation to bromocryptine treatment.
    Daemen BJ; Zwertbroek R; Elsinga PH; Paans AM; Doorenbos H; Vaalburg W
    Eur J Nucl Med; 1991; 18(7):453-60. PubMed ID: 1915472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptors in pituitary adenomas: PET visualization with 11C-N-methylspiperone.
    Muhr C; Bergström M; Lundberg PO; Bergström K; Hartvig P; Lundqvist H; Antoni G; Långström B
    J Comput Assist Tomogr; 1986; 10(2):175-80. PubMed ID: 3485123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiological control of prolactin adenomas treated with bromocriptine].
    Metzger J; Gardeur D; Pehuet M; Houlbert D
    Ann Med Interne (Paris); 1982; 133(1):59-60. PubMed ID: 7065592
    [No Abstract]   [Full Text] [Related]  

  • 15. Positron emission tomography in acromegaly and other pituitary adenoma patients.
    Muhr C
    Neuroendocrinology; 2006; 83(3-4):205-10. PubMed ID: 17047384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic imaging of dopamine receptors in pituitary adenomas.
    de Herder WW; Reijs AEM; Feelders RA; van Aken MO; Krenning EP; van der Lely AJ; Kwekkeboom DJ
    Eur J Endocrinol; 2007 Apr; 156 Suppl 1():S53-S56. PubMed ID: 17413189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of bromocriptine to maintain reduction in size of a macroprolactinoma.
    Breidahl HD; Topliss DJ; Pike JW
    Br Med J (Clin Res Ed); 1983 Aug; 287(6390):451-2. PubMed ID: 6411170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid distribution and metabolism in pituitary adenomas using positron emission tomography with D-[11C]methionine and L-[11C]methionine.
    Bergström M; Muhr C; Lundberg PO; Bergström K; Lundqvist H; Antoni G; Fasth KJ; Långström B
    J Comput Assist Tomogr; 1987; 11(3):384-9. PubMed ID: 3494753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.
    Jones TH; Figueroa CD; Smith CM; Bhoola KD
    Agents Actions Suppl; 1992; 38 ( Pt 2)():175-82. PubMed ID: 1462825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Giant prolactinoma: where's the prolactin?
    Tailor C; Teo I; Sorisky A
    Clin Neurol Neurosurg; 2011 Nov; 113(9):810-2. PubMed ID: 21906866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.